<DOC>
	<DOCNO>NCT01870401</DOCNO>
	<brief_summary>To assess safety efficacy Lutonix Drug Coated Balloon ( DCB ) treatment stenosis occlusion native below-the-knee artery .</brief_summary>
	<brief_title>Lutonix DCB Versus Standard Balloon Angioplasty Treatment Below-The-Knee ( BTK ) Arteries</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>Male nonpregnant female ≥18 year age ; Rutherford Clinical Category 3 , 4 &amp; 5 ; Life expectancy ≥ 1 year ; Significant stenosis ( ≥70 % ) A patent inflow artery ; Target vessel ( ) diameter 2 4 mm ; Target vessel ( ) reconstitute ( ) ankle Pregnant planning become pregnant ; History stroke within 3 month ; History MI , thrombolysis angina within 30 day enrollment ; Planned major amputation ( either leg ) Prior major amputation amputation occur less one year prior enrollment patient independently ambulate ; GFR ≤ 30 ml/min per 1.73m2 ; Acute limb ischemia ; Instent restenosis target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>